Corporate Banner
Satellite Banner
Technology
Networks
Scientific Communities
 
Become a Member | Sign in
Home>News>This Article
  News
Return

Biosearch Technologies Licenses RNA FISH-based Inventions from UMDNJ

Published: Tuesday, March 19, 2013
Last Updated: Tuesday, March 19, 2013
Bookmark and Share
Stellaris® Probe alliance - NextGen Gene Expression™, SNP FISH™, and iceFISH™ in research and clinical applications.

Biosearch Technologies, Inc. (Biosearch) announced that the company has acquired exclusive worldwide rights to continuing Stellaris® RNA FISH based inventions from the University of Medicine and Dentistry of New Jersey (UMDNJ). In addition to single molecule detection of mRNA, lncRNA, and viral RNAs, Stellaris based methods have been extended to directly and quantitatively detect chromosomal diseases caused by translocations and aberrant splice junctions,(intron chromosomal expression – iceFISH™) and single-nucleotide polymorphisms (SNPs or SNP FISH™). Biosearch’s exclusive access to Stellaris probe design is offered complimentary at www.biosearchtech.com/stellarisdesigner.

“Stellaris Next-Gen gene expression methods deliver high-content analysis within cells and tissues, along with single-molecule detection and quantitation. While qPCR delivers only an average number of RNA transcripts across a population of cells and tissues, and depends on a series of events, including isolation, extraction, purification, amplification and probe analysis, Stellaris RNA FISH delivers directly detected ‘Seeing is Believing’ satisfaction, that eliminates the multiple qPCR processing complexities, costs and blind eye analysis”, says Marc Beal, Director of Corporate Development at Biosearch. “In addition, for the first time, and in the same reaction, researchers and clinicians can simultaneously perform gene expression and chromosomal analysis in combination with Immunofluorescence (IF, IHC). This unique property of Stellaris probes enables transactional analysis from transcription through translation at the single-cell and single-molecule level.”

“Chromosomal paints are just the latest in a series of continuing developments of Stellaris-based tools”, says Arjun Raj, co-inventor of the Stellaris based RNA FISH technology. “We believe our chromosomal paints will provide a simple and effective method for visualizing chromosome structure while simultaneously detecting mRNA levels in single cells. Furthermore, we are very excited to be developing new Stellaris-based assays for long non-coding RNA, allowing us to peer into the ‘dark matter’ of the genome. We are also working on a number of exciting new tools based on the use of Stellaris in the lab, and we are very excited about working with Biosearch to bring these methods to the market. These include assays for live cell imaging.”

"The single-molecule sensitivity afforded by Stellaris probes is providing unprecedented insights into diverse biological processes ranging from RNA localization, RNA processing, the assessment of noise in gene expression. The availability of pre-labeled sets of probes from Biosearch is a tremendous help to cell biologists who no longer need to be concerned with the complexities of probe selection and probe chemistry,” says Sanjay Tyagi, co-inventor of Stellaris based RNA FISH technology.


Further Information
Access to this exclusive content is for Technology Networks Premium members only.

Join Technology Networks Premium for free access to:

  • Exclusive articles
  • Presentations from international conferences
  • Over 2,400+ scientific posters on ePosters
  • More Than 3,700+ scientific videos on LabTube
  • 35 community eNewsletters


Sign In



Forgotten your details? Click Here
If you are not a member you can join here

*Please note: By logging into TechnologyNetworks.com you agree to accept the use of cookies. To find out more about the cookies we use and how to delete them, see our privacy policy.

Related Content

Biosearch Announces Acquisition of European Companies DNA Technology and VitraBio
Acquisition marks Company’s increasing commitment to support European biotechnology and diagnostic markets.
Tuesday, July 23, 2013
Biosearch Technologies Launches New, ISO Certified GMP Production Facility
Biosearch Technologies, Inc. (Biosearch) announced the relocation of its GMP manufacturing process into a new, state-of-the-art GMP production facility in Novato, California.
Thursday, April 18, 2013
Biosearch Acquires Worldwide Rights to Non-FRET Probes Patents
Company has acquired rights from UMDNJ to United States Patent 6,150,097.
Thursday, August 23, 2012
Biosearch Appoints Uniscience as Brazilian Distributor
Uniscience to sell, market, and support Biosearch’s inventoried and custom products in the country of Brazil.
Tuesday, May 22, 2012
Biosearch and IMDx Finalize cGMP Oligo Supply and Licensing Agreements for IVD Products
Biosearch will manufacture cGMP oligonucleotides for IMDx for use in human in-vitro diagnostics.
Wednesday, March 16, 2011
Biosearch Technologies Licenses Access to new CDC “PDM” H1N1 Signatures
New “pdm” panel is optimized to achieve enhanced sensitivity and specificity for H1N1 specimen.
Friday, November 19, 2010
Biosearch Technologies and DuPont Qualicon Finalize Scorpion Supply and BHQ, CAL Fluor and Quasar Licensing Agreements for Food Safety Diagnostics
Biosearch Technologies Inc. today announced that the company has licensed access to the BHQ®, CAL Fluor® and Quasar® patents to DuPont Qualicon.
Thursday, October 28, 2010
Biosearch and Seegene Finalize Oligonucleotide Supply and BHQ®, CAL Fluor® and Quasar® Licensing Agreements
Biosearch will manufacture both research and IVD grade oligonucleotides for Seegene.
Thursday, October 21, 2010
Biosearch Technologies Awarded Second Phase II Army SBIR Grant
The $750,000+ Phase II grant will continue the design and development of accurate assays for pathogens of military importance.
Thursday, October 14, 2010
Biosearch Technologies Awarded Phase II Army SBIR Grant
The $800,000+ Phase II grant is aimed to back the design and development of rapid and accurate assays for pathogens of military importance.
Thursday, September 23, 2010
Biosearch Technologies Expands Licensing of QIAGEN Scorpions®
According to the agreement, the company obtains rights to manufacture primer assays for research, applied markets and infectious diseases.
Friday, August 13, 2010
Biosearch Technologies Signs Exclusive License for Single Molecule FISH Technologies from UMDNJ
Biosearch owns the exclusive rights to manufacture, catalogue and sell validated RNA FISH probes, assays and kits.
Sunday, August 08, 2010
Biosearch Expands Licensing of Roche Patents to Manufacture Kits Targeting the in-vitro Diagnostic Industry
License allows Biosearch to develop kits comprising of probes, primers, enzymes to amplify and detect diagnostic targets.
Wednesday, March 10, 2010
Biosearch Technologies Issued Two new Patents
The new patents comprise “Luminescent Metal Ion Complexes” and “Inducible fluorescence assay.”
Tuesday, March 09, 2010
Biosearch Technologies Selected for SBIR Grants Issued by the DoD for Disease Detection
Both the Phase I grants aim to develop sensitive analyte specific reagents for a total of twelve pathogens of military importance.
Friday, October 09, 2009
Scientific News
Study Finds Brain Chemicals that Keep Wakefulness in Check
Researchers to develop new drugs that promote better sleep, or control hyperactivity in people with mania.
Sorting Through Cellular Statistics
Aaron Dinner, professor in chemistry, and his graduate student Herman Gudjonson are trying to read the manual of life, DNA, as part of the Dinner group’s research into bioinformatics—the application of statistics to biological research.
Playing 'Tag' with Pollution lets Scientists See Who's It
Using a climate model that can tag sources of soot from different global regions and can track where it lands on the Tibetan Plateau, researchers have determined which areas around the plateau contribute the most soot — and where.
Women’s Immune System Genes Operate Differently from Men’s
A new technology reveals that immune system genes switch on and off differently in women and men, and the source of that variation is not primarily in the DNA.
Long Telomeres Associated with Increased Lung Cancer Risk
Genetic predisposition for long telomeres predicts increased lung adenocarcinoma risk.
First Artificial Ribosome Designed
Researchers at the University of Illinois at Chicago and Northwestern University have engineered a tethered ribosome that works nearly as well as the authentic cellular component, or organelle, that produces all the proteins and enzymes within the cell.
High-Resolution 3D Images Reveal the Muscle Mitochondrial Power Grid
NIH mouse study overturns scientific ideas on energy distribution in muscle.
Expanding the Brain
A team of researchers has identified more than 40 new “imprinted” genes, in which either the maternal or paternal copy of a gene is expressed while the other is silenced.
Identifying a Key Growth Factor in Cell Proliferation
Researchers discover that aspartate is a limiter of cell proliferation.
Study Uncovers Target for Preventing Huntington’s Disease
Scientists from Cardiff University believe that a treatment to prevent or delay the symptoms of Huntington’s disease could now be much closer, following a major breakthrough.
Scroll Up
Scroll Down
Skyscraper Banner

Skyscraper Banner
Go to LabTube
Go to eposters
 
Access to the latest scientific news
Exclusive articles
Upload and share your posters on ePosters
Latest presentations and webinars
View a library of 1,800+ scientific and medical posters
2,400+ scientific and medical posters
A library of 2,500+ scientific videos on LabTube
3,700+ scientific videos
Close
Premium CrownJOIN TECHNOLOGY NETWORKS PREMIUM FREE!